Objective: Kisspeptins were recently identified as hypothalamic neuropeptides that control GnRH release at pubertal onset and in adults via the activation of KISS-1 receptor (KISS1R). Here, we have tested whether the fetal activation of the gonadotropic axis is related to the hypothalamic expression of kisspeptins and KISS1R.
T he timing of human gonadotropic axis development has been relatively well documented (1) (2) (3) (4) . Neurons that produce GnRH appear in the hypothalamus at about 40 d of gestation after a long migration along the olfactory tract (5) . Concomitantly, gonadotropes develop in the pituitary, in which they begin synthesizing both LH and FSH at 9 wk of gestation (WG) (6) . Release of these two hormones into the fetal circulation starts at 12 WG (2). Testosterone becomes detectable in the blood of male fetuses at 12-14 wk (7) and leads to masculinization. At full term, fetal serum testosterone levels are very low, with no significant difference between males and females (8) . In female fetuses, serum LH and FSH levels at midgestation are within the range found in postmenopausal women (2, 4) , whereas in male fetuses, LH levels are similar to those in adult males (2, 4, 9) . FSH levels in males remain very low throughout gestation (2, 4, 9) . However, in both sexes, fetal serum gonadotropin levels are low or even undetectable values at the end of gestation (2, 4, 9) .
The mechanisms underlying the sexual dimorphism in gonadotropin levels in fetus and the negative regulation of the fetal gonadotropic axis remain poorly understood. Androgens contribute to inhibit the gonadotropic axis during gestation in male macaques (10) . However, in human fetuses, pituitary LH and FSH contents are higher in female than in male around 20 WG (11) , when the hypothalamic GnRH content is similar in both males and females (12) and fetal serum testosterone is back to low levels after the masculinization peak in male fetuses (13) . The regulation of gonadotropin synthesis and secretion during gestation and at the end of gestation may thus involve a more complex mechanism than only a steroid-induced negative feedback.
Kisspeptins were recently identified as the most powerful activators of GnRH secretion (14) . Kisspeptins are products of the KISS1 gene and activate KISS1 receptor (KISS1R), a G protein-coupled receptor expressed in GnRH neurons (14) . KISS1R loss-of-function mutations have been identified in patients with gonadotropic deficiency, indicating that functional integrity of the kisspeptin neuroendocrine system is required for normal gonadotropic axis activation at puberty and continuing function in adulthood (15) (16) (17) (18) . Micropenis and bilateral cryptorchidism may be noted at birth in males with KISS1R mutations, indicating a role for kisspeptins in gonadotropic axis activation during fetal development (16) . However, the timing of gonadotropic axis activation by kisspeptins in fetuses remains unknown. The hypothalamic distribution of kisspeptin-expressing neurons has been mainly studied in prepubertal and adult animals. In rodents, kisspeptins immunoreactivity has been found in the arcuate nucleus (ARC) and rostral periventricular area of the third ventricle (19) . In sheep, kisspeptin neurons predominate in the ARC and are scarce in the preoptic area (20, 21) . In monkeys and humans, kisspeptin expression has been documented in the ARC (22) (23) (24) and in a more rostrally located periventricular zone (23) . The distribution of KISS1R-expressing neurons has been reported by in situ hybridization (25, 26) or with a reporter gene (27) . The distribution of the kisspeptin-and KISS1R-expressing neurons has not been reported in the fetus.
Here we investigated whether changes in gonadotropic axis regulation during human fetal development were related to variations in the hypothalamic expression of kisspeptin and KISS1R. Fetal serum LH and FSH levels as well as pituitary LH and FSH contents were measured during the second and third trimesters of gestation. Immunohistochemistry was then used to evaluate the timing of hypothalamic kisspeptins, KISS1R, and GnRH expression. These expressions were then compared with variations in fetal serum LH and FSH levels.
Materials and Methods

Fetal human tissues
Informed consent was obtained from all parents in accordance with French legislation. The study was approved by the appropriate ethic committee. We obtained 10 fetal brains from the products of therapeutic or spontaneous abortions. Delivery usually occurred within 24 h after the death of the fetus, and a fetopathological examination was performed within 24 h after delivery, which ensured excellent preservation of the brains. The gestational age of each fetus was evaluated based on crown-rump length measured on the first-trimester sonogram and was confirmed during the fetopathological examination based on fetal biometry and on organ and skeletal maturation. The brains were removed, fixed in 10% buffered formalin with 3 g/liter of ZnSO 4 for approximately 3-4 wk, and cut into coronal sections 0.5 cm in thickness for routine examination. Hypothalami were collected and embedded in paraffin. Serial 10-m-thick sections were mounted on Superfrost Plus slides (Fisher Scientific, Illkirch, France). One of 10 sections was stained with hematoxylin-eosin for anatomic localization. For pituitaries, two pituitaries for each sex and each developmental age (16 in total) were collected and prepared as described above.
Antibodies
A polyclonal antibody against a KISS1R peptide (NH2-GLCVLGEDNAPL-COOH) was produced in rabbits (Eurogentec, Liege, Belgium). This peptide sequence corresponding to the C-terminal end (387-398) of KISS1R had a good quality index of immunogenicity and low homology in blast analysis. The antibody was called gp74. A 1:1000 dilution was used for Immunohistochemistry and a 1:5000 dilution for Western blot. The other primary antibodies were rabbit anti-kisspeptin-10 (Kp-10) (no. 564, 1:1000) (20) ; guinea pig anti-LH, anti-FSH, and anti-GH antibodies (1:1000; The National Hormone and Peptide Program, Torrance, CA), and a rabbit anti-GnRH1 (no. ab5617, 1:1000; Abcam, Cambridge, UK). The monoclonal rat anti-HA was used at 0.02 g/ml (3F10; Roche Diagnostics, Meylan, France).
Immunohistochemistry
Sections were dewaxed and were incubated for 20 min at 98 C in 10 mmol/liter sodium citrate (pH 6.0) for antigen retrieval and cooled at room temperature. Endogenous peroxidase activity was inactivated in 3% H 2 O 2 . The sections were then washed in PBS and blocked for 30 min in PBS supplemented with 3% BSA, 0.2% Triton X-100 (Sigma-Aldrich, Saint-Quentin Fallavier, France) before incubation with primary antibodies overnight at 4 C. After three washes in PBS-0.2% Tween 20, biotinconjugated anti-guinea pig or antirabbit antibodies (Ultratech horseradish peroxidase detection system kit; Immunotech, Marseille, France) were added. The sections were then washed intensively with PBS and incubated with peroxidase-conjugated streptavidin for 1 h at room temperature. 3,3-Diaminobenzidine tetrahydrochloride (Dako, Trappes, France) was used as a substrate for peroxidase activity. Negative controls were tissue sections incubated without primary antibody and with concentration-matched secondary antibody and streptavidin. The sections were counterstained with Mayer hemalun, mounted in Pertex medium (Histolab Products, Gothenburg, Sweden), and examined under a DMR microscope (Leica, Heidelberg, Germany). Hypothalamic nuclei were characterized as reported by Koutcherov et al. (28) . Images were acquired with a DFW-SX900 camera (Sony, Tokyo, Japan) and Inspector software (Matrox Imaging, Québec, Canada).
Hormone assays
FSH and LH were assayed using the Advia Centaur CP immunochemiluminometric immunoassay system (Siemens, Saint Denis, France) (29) in 40 cord blood samples (25 males and 15 females). The fetuses used to determine normal values had no endocrine or chromosomal abnormalities. After centrifugation, the serum was recovered and stored at Ϫ20 C until analyzed. FSH and LH were measured in singlicate. The sensitivity thresholds for LH and FSH were 0.07 and 0.3 IU/liter, respectively. All values below 0.1 IU/liter for LH and 0.3 IU/liter for FSH were recorded as zero. The LH and FSH assays showed no significant cross-reactivity with TSH, human chorionic gonadotropin, or prolactin.
Statistical analysis
Statistical analyses were performed using Prism 5 software (GraphPad, San Diego, CA). Graphs of LH and FSH concentrations against gestational age were plotted, and nonlinear regression was performed using a Lorentzian distribution. Two-way ANOVA with Bonferroni's posttest correction was used to compare cell counts between males and females and between gestational ages. Values of P Ͻ 0.05 were considered significant.
Results
Serum LH and FSH levels decrease during the second part of gestation
Serum LH and FSH levels were measured in male (n ϭ 25) and female (n ϭ 15) fetuses from 22 to 40 WG. In females, LH and FSH concentrations decreased from postmenopausal values at 22 WG to very low or nearly undetectable values at 40 WG (Fig. 1A ). LH and FSH decreased rapidly between 22 and 32 WG, after which LH and FSH levels remained very low until full term (Fig. 1A) . In males, LH decreased steadily from normal adult levels for males at 22 WG to very low values at full term (Fig. 1B) . FSH levels in male fetuses remained very low from midgestation to full term (Fig. 1B) .
FSH and LH pituitary contents are highly variable during gestation
To evaluate gonadotropin synthesis by the pituitary during gestation, the ratio of LH-(LHϩ) and FSH (FSHϩ)-expressing cells over the total number of cells were quantified in five different areas of the anterior pituitary ( Fig. 2A) males and females at 38 -40 WG. GHϩ cells differed between males and females only at 30 -31 WG (Fig. 2C) . In both sexes, GHϩ cells increased slightly from 15-16 WG to full term.
Kisspeptins and KISS1R are expressed in fibers and perykarya of fetal hypothalamus neurons
To investigate the role of the hypothalamus in the dynamic regulation of gonadotropin synthesis and secretion, we conducted immunohistochemistry of GnRH, kisspeptins, and KISS1R expression at similar developmental stages to those used for investigations of the pituitary. The subcellular location of GnRH, kisspeptins, and KISS1R immunolabeling was first analyzed.
GnRH staining was observed in the perikarya and fibers of hypothalamic neurons (30) . A rabbit polyclonal antibody raised against the C terminus of KISS1R (gp74) was used to investigate KISS1R expression (Fig. 3A) . gp74 was first characterized by Western blotting of membrane proteins extracted from human embryonic kidney 293 (HEK293) cells expressing recombinant human hemagglutinin (HA)-KISS1R. gp74 revealed a single band at 64 or at 44 kDa after protein deglycosylation with peptide N-glycosidase F (PNGase F) (Supplemental Data, published on The Endocrine Society's Journals Online web site at http://jcem.endojournals.org, and Fig. 3B ). These two bands were also observed using an antibody against the N-terminal HA tag (3F10) (Fig. 3B) . The 44-kDa band is the molecular mass of the primary amino acid sequence of KISS1R (http://www.uniprot.org); the 64-kDa band corresponds thus to the N-glycosylated KISS1R. Immunostaining with gp74 and 3F10 was similar on permeabilized HEK293 cells transiently expressing HA-KISS1R (Fig.  3C) . Lastly, immunostaining in the hypothalamus (Fig.  3D, left panel) was blocked by gp74 preadsorption with the antigenic peptide (Fig. 3D, right panel) . gp74 was thus validated as an antibody against KISS1R. gp74 was therefore used to immunolabeled KISS1R in the fetal hypothalamus. KISS1R immunoreactivity was observed not only in fibers but also in perikarya of hypothalamic neurons in several nuclei (Fig. 4) .
For kisspeptin immunostaining, it was weak and mainly located in fibers, although few perikarya were stained in the ARC and the median eminence (ME) (Fig. 4) .
Kisspeptins and KISS1R immunostaining decreases in the tuberal hypothalamus at the end of gestation
Nuclei expressing GnRH, kisspeptins, and KISS1R in the anterior hypothalamus (Fig. 5A ) and tuberal hypothalamus (Fig. 5B) were then assessed [Supplemental Fig.  1 for the levels of hypothalamic coronal sections (31)]. At 15-16 WG (n ϭ 2 hypothalami), GnRH immunoreactivity was found in the ventromedial nucleus (VMH), ME, supraoptic nucleus (SON), and paraventricular nucleus (Pa) along the third ventricle, and weak immunoreactivity for kisspeptins and KISS1R was seen chiefly in the ME and SON. At 21-23 WG (n ϭ 3) and 30 -31 WG (n ϭ 3), staining for GnRH, kisspeptins, and KISS1R appeared more intense than at 15-16 WG in the Pa, ARC, ME, and SON. Immunoreactive signals for KISS1R in the Pa, ARC, and SON were mainly located within the cell bodies, whereas in the ME it was found in fibers (Supplemental Fig. 2 ). At 30 -31 WG, these nuclei exhibited immunoreactivity for GnRH, kisspeptins, and KISS1R. At 38 -40 WG (n ϭ 2), the staining pattern differed clearly across section levels. In the Pa and SON, persistent staining for GnRH, kisspeptins, and KISS1R was observed at all developmental stages (Supplemental Fig. 2) . At the tuberal level, kisspeptins and KISS1R staining disappeared from the VMH, ARC, and ME (Supplemental Fig. 2) , and only GnRH staining persisted in the VMH and ME.
Serum LH and FSH levels are normal for the developmental age in an arhinencephalic fetus of 23 WG
To analyze the link between GnRH, LH, and FSH levels at midgestation, we measured the LH and FSH serum levels and counted the GnRH neurons in the hypothalamus of an arhinencephalic female fetus, which was obtained after therapeutic abortion at 23 WG for trisomy 5. The GnRH neuron number was at 24% of a control fetus (Table 1) , as expected (30), but LH and FSH serum levels were high, in accordance with his developmental age (Fig. 1A) .
Discussion
The recent identification of kisspeptins as major regulators of the gonadotropic axis has provided new insights into the neuroendocrine regulation of pubertal onset, LH ovulatory surge, and ontogenesis of the gonadotropic axis. Fetal activation of the hypothalamo-pituitary unit is not required for masculinization of the male fetus but is crucial for the development of the testes and penis and for gametogenesis. Previous studies documented sexual dimorphism of gonadotropic axis activation and its inhibition at the end of gestation (2, 4, 9) . The mechanisms underlying this regulation remained unknown. We therefore investigated whether variations in LH and FSH synthesis and secretion in fetuses were related to the expression of kisspeptins and KISS1R in the hypothalamus. Our results show that kisspeptins and KISS1R are expressed in the rostral hypothalamic nuclei and tuberal hypothalamus early in development, together with GnRH. Kisspeptin and GnRH do not seem to be involved in regulating LH and FSH synthesis and secretion in the first half of gestation. At full term, in contrast, LH and FSH levels are very low in fetal blood, and the kisspeptin/KISS1R immunostaining has disappeared in the tuberal hypothalamus.
The distribution of kisspeptin-expressing neurons in the hypothalamus has been extensively studied in mammalians using highly specific antibodies (19, 20, 23, 24,  32) . The dual location of kisspeptin-expressing neurons in a rostral periventricular region and more caudally in the infundibulum of the fetal human hypothalamus is similar to the expression pattern reported in the adult human hypothalamus (23) . The periventricular region exhibiting kisspeptin expression in our study corresponds to the rostral periventricular area of the third ventricle in rodents (32) . Kisspeptin-expressing neurons were also found more caudally, in the ARC and ME, as reported in other mammalians (20, 23, 24, 32, 33) .
KISS1R immunostaining has not been previously reported. Here we show that KISS1Rϩ neurons were present in the SON, Pa, ARC, and VMH nuclei as well as in the ME. These sites of KISS1R expression in the rostral periventricular region of the hypothalamus, ARC, and ME are similar to those reported in rats (34) and monkeys (35) . A knock-in LacZ strategy found no evidence of KISS1R-expressing neurons in the ARC or periventricular region of the mouse hypothalamus (27) . The reason for this difference between adult rats and mice, on the one hand, and adult rodents and human fetuses, on the other hand, is not obvious. This may reflect the low sensitivity of the LacZ strategy rather than a major difference in KISS1Rϩ neuron location across species. Further studies using an antibody specific of rodent KISS1R are needed to conclude about possible differences between fetuses and adults.
Interestingly, KISS1R-labeled fibers were far more numerous than GnRH-labeled fibers, indicating that some KISS1R-expressing neurons do not express GnRH, as previously reported in adult rodents (27) . Kisspeptin immunoreactivity was observed in the SON, as previously reported in adult female mice (32) . We observed kisspeptin staining in both the perikarya and the fibers of SON neurons, whereas Clarkson et al. (32) reported staining confined to fibers in mouse. Evidence of KISS1R expression in the SON was not detected in previous studies using in situ hybridization (26) or ␤-galactosidase staining (27) , whereas in vivo Kp-10 administration induced oxytocin release (36) . In vivo Kp-10-induced oxytocin release is due to a peripheral and not to a central effect of Kp-10 (37). However, kisspeptins and KISS1R costaining in the fetal SON in our study suggests that kisspeptins may also have central effects on SON neurons. Further studies are needed to characterize the function of hypothalamic kisspeptins in the fetal SON and to determine whether this function is specific of fetal life.
Hypothalamic-pituitary-gonadal activation varies considerably during fetal life. In human male fetuses, testicular androgen production starts at about 9 WG and shows a peak at about 12-14 WG, which is under the regulation of human chorionic gonadotropin (13) . This testosterone synthesis is crucial for masculinization of the male fetus. It represents the first wave of sex steroid production in the fetus. At the beginning of the second trimester, human chorionic gonadotropin production declines and is progressively replaced by LH. In the meantime, serum testosterone levels decline in the male fetus (13) . Testosterone-induced negative feedback suppressing LH and FSH synthesis and secretion has been documented in fetal male monkeys (10) . The increases in LH synthesis and secretion at the beginning of the second trimester may therefore be related to the decrease in testosterone levels. However, testosterone peaks only in male fetuses. Therefore, the very high fetal serum levels of LH and FSH at 20 -22 WG in females cannot be explained by weakening of the negative feedback induced by steroid hormones.
Gonadotropes and thyrotropes are the last cells to differentiate in the human pituitary (38) . The increasing numbers of gonadotropes up to 21-23 wk for LH and 30 -31 wk for FSH confirms that differentiation toward gonadotropes persists during the second trimester of gestation in humans (3), independently of sex steroids. The exact role for the hypothalamus in the development of the fetal gonadotropic axis is poorly described. In anencephalic fetuses, gonadotrope development is normal up to 17-18 wk of gestation, whereas gonadotropes are considerably scarce at 26 WG and almost completely absent at 32 WG (39). The high blood LH and FSH levels with low numbers of GnRH neurons in an arhinencephalic female fetus confirm that gonadotropin synthesis and secretion during the first part of gestation is independent from the hypothalamus.
In contrast, GnRH is necessary for the normal development of the gonadotropic axis during the second part of gestation. Indeed, micropenis and bilateral cryptorchidism occur in newborn boys with GnRHR mutations (40, 41) . KISS1R activation is also required for normal development of the gonadotropic axis (16) . Thus, there is a critical period during gestation when the pituitary exits from a GnRH-independent program and comes under regulation by GnRH. Our data suggest that this critical period may occur relatively late in gestation. After 20 -22 WG, fetal serum FSH levels drop rapidly, whereas FSHϩ cells continue to increase in the pituitary up to 30 -31 WG. Given that cultured human fetal pituitary cells respond to GnRH neurons were counted as described (30) . In a control fetus, the number of GnRH-immunoreactive neurons was 215 based on examination of 158 hypothalamic sections covering a total thickness of about 630 m (30).
GnRH at 14 WG and that this response seems proportional to gestational age (38) , the decrease in serum LH and FSH levels cannot be explained by declining GnRHRinduced signaling pathway activity in gonadotropes. Additional loops regulating LH and FSH secretion via modulation of GnRH release by hypothalamic neurons or independently of GnRH therefore appear in human fetus after midgestation. Our results show that kisspeptins and KISS1R staining appears in the VMH and ME at the beginning of the second trimester of gestation, increases up to 30 -31 WG, and then decreases to undetectable values by full term. The increase in kisspeptin/KISS1R hypothalamic staining between 21-23 and 30 -31 WG contrasts with the decreases in fetal blood LH and FSH levels, indicating they are not related to kisspeptin activity. In contrast, the decline in LH and FSH synthesis at the end of gestation is associated with disappearance of kisspeptin and KISS1R staining in the VMH, ARC, and ME. This low kisspeptin and KISS1R expression in the tuberal hypothalamus probably decreases the GnRH release and therefore gonadotropin synthesis and secretion.
This low kisspeptin and KISS1R expression may be related to steroid-induced negative feedback on kisspeptin synthesis. Indeed, the mediobasal hypothalamus is the relay of the sex steroid-induced negative feedback loop that decrease KISS1 expression in nonhuman primates and rodents (42, 43) and in humans (22) . The persistent immunostaining for kisspeptins and KISS1R in the Pa at the end of gestation shows that the differential regulation of kisspeptin synthesis between the ARC and Pa appears early during the development. It suggests that the 17␤-estradiolmediated positive feedback on kisspeptin synthesis is already developed in the Pa. A steroid-independent mechanism that differentially regulates kisspeptin and KISS1R expression between rostral and tuberal hypothalamus is another possibility. The role of kisspeptins expressed at the end of gestation in the Pa is unclear. Because KISS1R staining disappeared in the ME, they do not seem to regulate the GnRH release from terminal extremities of GnRH neurons. They could activate KISS1R expressed in GnRH neurons located in Pa but also in other KISS1R-expressing neurons that remain to be characterized (44) .
In conclusion, this study brings new insights into gonadotropic axis regulation in human fetuses. Our data indicate a developmental sequence inaugurated by increases in LH and FSH synthesis and secretion, which seem independent from hypothalamic regulation and lead to adult levels of blood LH and FSH levels around 20 -22 WG. With further fetal development, LH and FSH synthesis and secretion are controlled by GnRH. Although this regulation does not seem to be under kisspeptins control between 20 and 31 WG, the complete gonadotropic axis inhibition seen by the end of gestation is associated with decreased kisspeptins and KISS1R expression in the tuberal hypothalamus. Further studies are necessary to delineate the mechanisms underlying the progressive relay of the hypothalamus in the negative regulation of the gonadotropic axis during development. This dynamic regulation of the gonadotropic axis, which takes place around midgestation, may be critical to determine the timing of the hypothalamic-pituitary-gonadal reactivation at puberty and fertility in adults.
